Hiroaki Hemmi

Title: Hiroaki Hemmi: Innovator in Immunology

Introduction

Hiroaki Hemmi is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work on transgenic mice. His research focuses on understanding the immune response to bacterial infections, which has important implications for medical science.

Latest Patents

Hiroaki Hemmi holds a patent for a transgenic toll-like receptor 9 (TLR9) mouse. This invention provides a receptor protein that specifically recognizes bacterial DNA containing an unmethylated CpG sequence. The patent details a method for screening DNA encoding this receptor protein using BLAST search. It also describes the isolation of a full-length cDNA from a mouse macrophage cDNA library. The sequence of the cDNA is analyzed to confirm that it is TLR9, which includes conserved regions such as LRR and TIR regions. Furthermore, a knockout mouse is produced to validate that TLR9 acts as a receptor protein for oligonucleotides with unmethylated CpG sequences found in bacterial DNA.

Career Highlights

Hiroaki Hemmi has worked with prestigious organizations, including the Japan Science and Technology Agency and the Independent Administrative Institution Japan Science and Technology Agency. His career has been marked by a commitment to advancing scientific knowledge and developing innovative solutions in immunology.

Collaborations

Hiroaki Hemmi has collaborated with notable scientists, including Shizuo Akira, enhancing the impact of his research through shared expertise and insights.

Conclusion

Hiroaki Hemmi's contributions to immunology through his patent on TLR9 mice exemplify his dedication to scientific innovation. His work continues to influence the understanding of immune responses to bacterial infections, paving the way for future advancements in the field.